A Phase I/II Study of First Line Gemcitabine, Cisplatin and MEK162 in Advanced Biliary Tract Carcinoma
Active, no longer recruiting
Phase of Trial: Phase I/II
Latest Information Update: 24 May 2017
At a glance
- Drugs Binimetinib (Primary) ; Cisplatin; Gemcitabine
- Indications Biliary cancer; Gallbladder cancer
- Focus Adverse reactions; Therapeutic Use
- 17 May 2017 Planned End Date changed from 1 Apr 2017 to 1 Apr 2018.
- 17 May 2017 Planned primary completion date changed from 1 Apr 2017 to 1 Apr 2018.
- 21 Jan 2017 Results presented at the 2017 Gastrointestinal Cancers Symposium